+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 0 - 360Days
All Genders
ID07445763

Real-World Study of Maternal RSVpreF Vaccination Impact on Infant RSV-Related Respiratory Illness in Brazil

Led by Inova Medical · Updated on 2026-11-04

5000

Participants Needed

8

Research Sites

13 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting the TARSILA Study to evaluate the real-world effectiveness of maternal RSVpreF vaccination during pregnancy in Brazil. The study aims to measure how well this vaccine protects infants against respiratory syncytial virus RSV-associated acute respiratory illness ARI, including lower respiratory tract disease, by comparing infants with and without RSV infection. Two linked studies will take place one involving hospitalized infants and another involving infants treated as outpatients. The study includes two prospective, test-negative case-control designs conducted in Southern Brazil. The TARSILA Inpatient Study enrolls infants hospitalized for ARI, while the TARSILA Outpatient Study enrolls infants seen in outpatient healthcare settings for similar illnesses. Maternal vaccination status during pregnancy is recorded based on the Brazilian National Immunization Programs recommendations, focusing on vaccination between 240 to 366 weeks of gestation, with vaccination received at least 14 days before delivery. RSV testing is done using RT-qPCR on nasal swabs to classify infants as RSV-positive cases or RSV-negative controls. Participants are infants born in Brazil, up to 360 days old, meeting specific ARI symptom criteria. Data collection includes structured interviews with mothers and medical record reviews to assess vaccination status and other factors. Outcomes measured include hospitalization for lower respiratory tract disease and occurrence of acute respiratory illness in infants up to 180 days old. Enrollment runs from April 2026 to September 2028, with follow-up assessments based on clinical presentations and testing results.

CONDITIONS

Brief Title

TARSILA Real-World Evidence Study

Research Team

M

Maicon Falavigna, MD PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here